George Kopsidas

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Aprogen Inc., Aprogen Kic Inc., Cephalon Australia (Vic) Pty Ltd. Active years: 2009-2025.

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Melbourne, AU (2013)
Preston, AU (2009 - 2023)

Company Filing History:

Cephalon Australia (Vic) Pty Ltd

patent

4. 1 out of 9

Cephalon Australia Pty. Ltd.

Teva Pharmaceuticals Australia Pty Ltd

patents

Years Active: 2009-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410256 - Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases (2025-09-09),

2. 11542339 - Anti-CD43 antibody and use thereof for cancer treatment (2023-01-03),

3. 10822422 - Antibodies against TL1a and uses thereof (2020-11-03),

4. 10676531 - Anti-CD43 antibody and use thereof for cancer treatment (2020-06-09),

5. 8563697 - Anti-IL-12/IL-23 antibodies (2013-10-22),

6. 8530624 - Osteoprotegerin variant proteins (2013-09-10),

7. 8362208 - Immunoglobulins (2013-01-29),

8. 7612169 - Osteoprotegerin variant proteins (2009-11-03),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

This text is generated by artificial intelligence and may not be accurate.